The Vyvanse Controversy Continues: New Leaks Surface

Sep 4, 2024 · the u. s. Drug enforcement administration has increased the production limit for takeda pharmaceutical's adhd drug vyvanse and its generic versions by about 24% to. Apr 9, 2024 · in october of 2022, the fda announced a shortage of the adhd medication adderall. Since then, the supply has remained unreliable and other adhd medications like. As demand for stimulants like adderall and vyvanse soared, the fill rate for such prescriptions has dropped more than 10% in two years, according to a new analysis from health.

There are now 18 approved. Nov 17, 2023 · a u. s. Shortage of the new generic version of vyvanse, an adhd medication, is due in part to federal limits on production, according to an industry group representing generic. Sep 28, 2023 · it's been more than one year since the shortage of adhd medications began, and it continues. Patients still struggle to fill their prescriptions for adderall xr and other stimulants. We have recently learned that many insurance companies removed the brand name vyvanse from their formularies, even before pharmacies have the generic version in stock. In an attempt to help rectify the adhd medication shortfall, last august the food and drug administration approved the first generics of vyvanse, a popular medication used to treat both.